CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-20 | LEPORE PATRICK G Director | Purchase | +20,000 | $2.48 | $50K | 23,472 |
| 2023-03-20 | Harsch Mutya Chief Legal Officer and GC | Purchase | +10,000 | $2.50 | $25K | 22,721 |
| 2022-12-31 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −1,813 | $0.15 | $272 | 229,144 |
| 2022-12-31 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −1,720 | $0.15 | $258 | 220,252 |
| 2022-12-31 | Zeronda Tyler Chief Financial Officer | Shares withheld for taxes | −354 | $0.15 | $53 | 173,005 |
| 2022-12-31 | Domzalski David President and CEO | Shares withheld for taxes | −10,685 | $0.15 | $2K | 1,064,290 |
| 2022-11-30 | Domzalski David President and CEO | Grant or award | +34,705 | $0.20 | $7K | 1,074,975 |
| 2022-09-30 | Zeronda Tyler CFO | Shares withheld for taxes | −353 | $0.22 | $79 | 173,359 |
| 2022-09-30 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −1,719 | $0.22 | $383 | 221,972 |
| 2022-09-30 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −1,813 | $0.22 | $404 | 230,957 |
| 2022-09-30 | Domzalski David President and CEO | Shares withheld for taxes | −10,683 | $0.22 | $2K | 1,040,270 |
| 2022-08-10 | Sandoval Elisabeth Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2022-08-10 | LEPORE PATRICK G Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2022-08-10 | Bruno Anthony D Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2022-08-10 | Basta Steven L Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2022-08-10 | BARBARI SHARON Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2022-06-30 | Zeronda Tyler CFO | Shares withheld for taxes | −354 | $0.39 | $138 | 173,712 |
| 2022-06-30 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −1,719 | $0.39 | $669 | 223,691 |
| 2022-06-30 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −1,813 | $0.39 | $705 | 232,770 |
| 2022-06-30 | Domzalski David President and CEO | Shares withheld for taxes | −10,683 | $0.39 | $4K | 1,050,953 |
Page 7 of 22 · 425 trades